SPRUCE BIOSCIENCES, INC.

SPRB · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 8 employees
99
SEC Filings
$43.99
Close 2026-10-26
8
Employees

Business Summary

Spruce Biosciences is a biopharmaceutical company founded in April 2016, focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. Its lead product candidate, TA-ERT (tralesinidase alfa), is an enzyme replacement therapy for Mucopolysaccharidosis Type IIIB (MPS IIIB), an ultra-rare fatal genetic disease with no approved therapies. The company seeks U.S. accelerated approval via a Biologics License Application and intends to build a specialized commercial organization in the U.S., EU, and UK, with regional collaborations in other international markets.

Latest Stock Quote

SPRB 2026-10-26 $43.99 O:$45.47 H:$45.47 L:$43.62 Vol:0.1M VWAP:$44.5486
origin leaf: null

Next Earnings

expected 2027-02-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-097558EDGAR95K words
2025-04-152024-12-310000950170-25-053945EDGAR94K words
2024-03-182023-12-310000950170-24-032819EDGAR100K words
2023-03-162022-12-310000950170-23-008456EDGAR99K words
2022-03-142021-12-310000950170-22-003582EDGAR100K words
2021-03-222020-12-310001564590-21-014593EDGAR98K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-092026-09-300001193125-26-452714EDGAR73K words
2026-08-122026-06-300001193125-26-345876EDGAR65K words
2025-11-102025-09-300001193125-25-274234EDGAR65K words
2025-08-142025-06-300000950170-25-108888EDGAR66K words
2025-05-062025-03-310000950170-25-064463EDGAR64K words
2024-11-122024-09-300000950170-24-124479EDGAR66K words
2024-08-122024-06-300000950170-24-095461EDGAR66K words
2024-05-132024-03-310000950170-24-058657EDGAR62K words
2023-11-132023-09-300000950170-23-062997EDGAR66K words
2023-08-142023-06-300000950170-23-042439EDGAR66K words
2023-05-152023-03-310000950170-23-021984EDGAR65K words
2022-11-102022-09-300000950170-22-024531EDGAR66K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-090001193125-26-452707EDGAR3K words
2026-08-120001193125-26-345874EDGAR3K words
2026-07-270001193125-26-316928EDGAR1K words
2026-03-200001193125-26-117888EDGAR2K words
2026-03-090001193125-26-097561EDGAR2K words
2026-02-050001193125-26-039399EDGAR2K words
2026-01-080001193125-26-007038EDGAR1K words
2025-12-150001193125-25-318488EDGAR1K words
2025-12-120001193125-25-317532EDGAR1K words
2025-11-100001193125-25-274216EDGAR2K words

99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

ultra-rare-neurological-genetic-diseases mucopolysaccharidosis-type-iiib-(mps-iiib) north-america european-union united-kingdom latin-america turkey asia fda-rare-pediatric-disease-designation fda-fast-track-designation fda-breakthrough-therapy-designation fda-orphan-drug-designation eu-orphan-drug-designation

Company Identity

CIK0001683553
TickerSPRB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.sprucebiosciences.com
Listed2020-10-09

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 2b396b55a9bb87c240000abb666c4da37c34984fba4891ff39b0abd18b18e54a
parent: e00d819e10fee315852131c01a8204381308be668cf4469a7003f311135d0afc
content hash: 142c717012a98b7126203b062c55780f52f76d7848cdf0dad5ecf14d2618bf23
signed: 2026-11-16T19:04:53.879Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SPRB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SPRB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SPRB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.